{"title": "Monitoring Disease Transmissibility of 2019 Novel Coronavirus Disease in Zhejiang, China", "doi": "10.1101/2020.03.02.20028704", "citation_id": "2020.03.02.20028704v1", "date": "2020-03-05", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.02.20028704", "abstract": "<p>We monitored the transmissibility of 2019 novel coronavirus disease in Zhejiang accounting the transmissions from imported cases. Even though Zhejiang is one of the worst-affected provinces, an interruption of disease transmission (i.e. instantaneous reproduction numbers &lt;1) was observed in early/mid-February after an early social-distancing response to the outbreak.</p>", "twitter_description": "We monitored the transmissibility of 2019 novel coronavirus disease in Zhejiang accounting the transmissions from imported cases. Even though Zhejiang is one of the worst-affected provinces, an interruption of disease transmission (i.e. instantaneous reproduction numbers <1) was observed in early/mid-February after an early social-distancing response to the outbreak.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThe work is supported by National Natural Science Foundation of China (31871340, 71974165).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nData are available from the authors upon reasonable request and with permission of the Zhejiang Provincial Center for Disease Control and Prevention.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.02.20028704v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.02.20028704v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.02.20028704v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/05/2020.03.02.20028704.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.02.20028704v1", "access_rights": "restricted", "authors": ["Ka Chun Chong", "Wei Cheng", "Shi Zhao", "Feng Ling", "Kirran N Mohammad", "Maggie Haitian Wang", "Benny Chung-ying Zee", "Lesley Wei", "Xi Xiong", "Hengyan Liu", "Jingxuan Wang", "Enfu Chen"]}